𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation

✍ Scribed by D. Seehofer; N. Rayes; R. Neuhaus; T. Berg; A. R. Müller; W. O. Bechstein; P. Neuhaus


Book ID
105841008
Publisher
Springer
Year
2000
Tongue
English
Weight
62 KB
Volume
13
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Multicenter study of lamivudine therapy
✍ Robert Perrillo; Jorge Rakela; Jules Dienstag; Gary Levy; Paul Martin; Teresa Wr 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Hepatitis B after liver transplantation is often fatal, and no proven medical therapy exists for this condition. We chose to study the potential efficacy of lamivudine therapy for patients with chronic hepatitis B after liver transplantation. Fifty-two patients with chronic hepatitis B after liver t

Prevention of hepatitis B recurrence aft
✍ Shusen Zheng; Yaomin Chen; Tingbo Liang; Anwei Lu; Weilin Wang; Yan Shen; Min Zh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

The aim of our study was to determine the outcomes of liver transplant recipients receiving either lamivudine (LAM) monotherapy or LAM combined with low-dose intramuscular (IM) hepatitis B Immunoglobulin (HBIG) therapy. We performed a retrospective review of the medical records of patients that had

Intramuscular hepatitis B immune globuli
✍ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Mutational pattern of hepatitis B virus
✍ Hans L. Tillmann; Christian Trautwein; Thomas Bock; Klaus H. Böker; Elmar Jäckel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 2 views

## Famciclovir (FCV) and lamivudine (LAM) reduce viral replication in patients with recurrent hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). Eighteen of 20 patients with insufficient response to FCV were treated with 100 mg LAM daily after OLT. These patients had s